The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-37966980
Key words
Full text:
1
Collection:
01-internacional
Health context:
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Hematologic Neoplasms
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Year:
2024
Document type:
Article